40 research outputs found
PDB5 COMPARISON OF CLINICAL EFFECTIVENESS AND SAFETY OF GLULISINE VERSUS INSULIN LISPRO, ASPART AND REGULAR HUMAN INSULIN IN PATIENTS WITH TYPE I AND 2 DIABETES
Get PDF
Identifying and Quantifying Genotypes in Polyclonal Infections due to Single Species
Get PDFThe combination of real-time PCR and capillary electrophoresis permits the rapid identification and quantification of pathogen genotypes
PRS9 COST OF COMMUNITY ACQUIRED PNEUMONIA (CAP) TREATMENT WITH KETEK (TELITHROMYCIN) VS CLARITHROMYCIN FROM PUBLIC PAYER PERSPECTIVE IN POLAND
No full text
PSY48 Indirect Costs of Systemic Lupus Erythematosus-Related Absenteeism in Poland: An Analysis Based on Social Insurance Institution Data
Get PDFPDB13 THE ESTIMATION OF POTENTIAL BUDGETARY IMPACT OF INSULIN GLARGINE IN POLISH SETTINGS
No full textPDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NAĂŹVE TO INSULIN TREATMENT WITH TYPE 2, BASELINE HBA1C ABOVE 8% AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?
No full text
